We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Daniel Tarsy

Daniel Tarsy MD

Professor in Neurology, Harvard Medical School; Director, Parkinson's Disease & Movement Disorders Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Dr. Daniel Tarsy is Professor in Neurology at Harvard Medical School and director of the Parkinson’s Disease & Movement Disorders Center at Beth Israel Deaconess Medical Center. He received his undergraduate degree at Cornell University and MD degree at NYU School of Medicine. He received neurology training at Boston University School of Medicine followed by fellowships in movement disorders at Massachusetts General Hospital and the Kings College Hospital/Institute of Psychiatry, London. He has carried out laboratory studies in the behavioral and biochemical pharmacology of brain neurotransmitters and clinical trials of new treatments for Parkinson’s disease, dystonia, tremor, and tardive dyskinesia. He established the stereotactic deep brain stimulation program and dystonia/botulinum toxin clinic at Beth Israel Deaconess Medical Center. He is past chair of the Movement Disorders Section of the American Academy of Neurology, has served on the board of the Parkinson’s Disease & Movement Disorders Society, and has served on the editorial boards of the journals Movement Disorders and Parkinsonism and Related Disorders.